Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Darias Zayas"'
Autor:
Waldo Hernández Sánchez, Aneisys González Gonzalez, Daniel Darias Zayas, Gongora Morales, Gismell Garcia Garcia, Ronny O. Pacheco
Publikováno v:
ITEGAM-JETIA, Vol 3, Iss 12 (2018)
El cultivo de células de mamíferos o superiores representa el principal eslabón productivo del Centro de Inmunología Molecular (CIM) y los fermentadores constituyen el corazón dentro de este engranaje de procesos productivos e investigativos. Po
Externí odkaz:
https://doaj.org/article/ea63f2fb5ffe468daa9640f926ff7a13
Autor:
Ronny O. Pacheco, Daniel Darias Zayas, Gismell Garcia Garcia, Waldo Hernández Sánchez, Aneisys González Gonzalez, Daniel Gongora Morales
Publikováno v:
ITEGAM- Journal of Engineering and Technology for Industrial Applications (ITEGAM-JETIA). 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76c9ecf7830f36a5a3db1f323e499c03
https://doi.org/10.5935/2447-0228.20170073
https://doi.org/10.5935/2447-0228.20170073
Autor:
Ricardo Cabanas Armada, Luis Valle Garrido, Daniel Darias Zayas, Agustín Lage Dávila, Luis Quevedo Sotolongo, Gretel Rodriguez Cruz, Giselle Saurez Martínez, Evelio González Dalmau, Carlos Cabal Mirabal, Mercedes Monzón Fernández, Martha Ríos Castillo, José Carlos Ugarte Suárez
Publikováno v:
Pediatrics International. 56:43-46
Background Nimotuzumab, a humanized monoclonal antibody anti-epidermal growth factor receptor, has been shown to improve survival and quality of life in patients with pediatric malignant brain tumor. It is necessary, however, to increase the objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c5a3ea28369218bf8215d7a9092294d
https://doi.org/10.1111/ped.12212
https://doi.org/10.1111/ped.12212
Autor:
Evelio Rafael González, Dalmau, Carlos, Cabal Mirabal, Giselle Saurez, Martínez, Agustín Lage, Dávila, José Carlos Ugarte, Suárez, Ricardo, Cabanas Armada, Gretel, Rodriguez Cruz, Daniel, Darias Zayas, Martha Ríos, Castillo, Luis, Valle Garrido, Luis Quevedo, Sotolongo, Mercedes Monzón, Fernández
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 56(1)
Nimotuzumab, a humanized monoclonal antibody anti-epidermal growth factor receptor, has been shown to improve survival and quality of life in patients with pediatric malignant brain tumor. It is necessary, however, to increase the objective response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e43709142249907eee71d529ebfe390b
https://pubmed.ncbi.nlm.nih.gov/24003867
https://pubmed.ncbi.nlm.nih.gov/24003867